Hi,
Nothing much to worry about. To me it looks like the growing up pains with any small company.
I reckon that the delay with ADAM may be due to software integration and that is always a hitch and always takes longer than planned.
The $1.5 million in cash trust may be for Dexion to be sure that they will get paid (otherwise they won't manufacture). The comment at the end of quarterly that this can be used when required leads me tothis conclusion.
Delays but we should get a bigger share of the market.
conflicting reports. , page-11
-
- There are more pages in this discussion • 28 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
